UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549

                                   FORM 10-QSB

|X|   Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
      Exchange Act of 1934 For the quarterly period ended February 28, 2005

|_|   Transition Report Pursuant to Section 13 or 15(d) of the Securities
      Exchange Act of 1934

            For the transition period from _________ to ___________

                       Commission File Number: 333-111996

                               SALMON EXPRESS INC.
        (Exact name of small business issuer as specified in its charter)


                Nevada                                      98-0228169
(State or other jurisdiction of incorporation  (IRS Employer Identification No.)
           or organization)


                  6604 Topaz Drive, Vernon, BC, Canada, V1H 1N8
                  ---------------------------------------------
                    (Address of principal executive offices)

                            (250) 558-0991 (Issuer's
                                telephone number)
       ------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)

Indicate by check mark whether registrant (1) has filed all reports required to
be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding twelve months or for such shorter period that the
Registrant was required to file such reports, and (2) has been subject to such
filing requirements for the past 90 days. Yes |_| No |X|

The number of shares outstanding of Registrant's common stock as of April 14,
2005 was: 15,040,000.

<PAGE>

PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements.




                               SALMON EXPRESS INC.
                          (A Development Stage Company)


                          INTERIM FINANCIAL STATEMENTS
                                   (Unaudited)

                                FEBRUARY 28, 2005
                            (Stated in U.S. Dollars)


<PAGE>


                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                             INTERIM BALANCE SHEETS
                            (Stated in U.S. Dollars)



<TABLE>
<CAPTION>
                                                                   FEBRUARY 28   NOVEMBER 30
                                                                  ------------- -----------
                                                                       2005       2004
                                                                   (Unaudited)  (Audited)
<S>                                                                 <C>         <C>
                                ASSETS

Current
Cash                                                                $     --    $  4,426
==========================================================================================
                             LIABILITIES

                               Current
                 Accounts payable and accrued liabilities           $  6,251    $  6,598
                                                                    ----------------------


                         STOCKHOLDERS' EQUITY

                             Common Stock
                                Authorized:
             50,000,000 common shares, par value $0.001 per share

                          Issued and outstanding:
                           15,040,000 common shares                   15,040      15,040


                        Additional paid-in capital                    19,960      19,960


           Deficit Accumulated During The Development Stage          (41,251)    (37,172)
                                                                    ----------------------
                                                                      (6,251)     (2,172)
                                                                    ----------------------

                                                                    $     --    $  4,426
==========================================================================================
</TABLE>

<PAGE>

   The accompanying notes are an integral part of these financial statements

                              SALMON EXPRESS INC.
                          (A Development Stage Company)

                        INTERIM STATEMENTS OF OPERATIONS
                                   (Unaudited)
                            (Stated in U.S. Dollars)

<TABLE>
<CAPTION>
--------------------------------------------------------------------------------------------------------------------
                                                                                                     CUMULATIVE
                                                                                                     PERIOD FROM
                                                                                                      INCEPTION
                                                          THREE MONTHS          THREE MONTHS         FEBRUARY 20
                                                              ENDED                ENDED               2003 TO
                                                           FEBRUARY 28          FEBRUARY 29          FEBRUARY 28
                                                              2005                  2004                2005
--------------------------------------------------------------------------------------------------------------------
<S>                                                    <C>                  <C>                   <C>
Revenue                                                $             -      $             -       $         -
                                                       -------------------------------------------------------------

Expenses
     General and administrative                                      823                 1,205           16,177
     Professional fees                                             3,256                 5,000           25,074
                                                       -------------------------------------------------------------
                                                                   4,079                 6,205           41,251
                                                       -------------------------------------------------------------

Net Loss For The Period                                $          (4,079)   $           (6,205)   $     (41,251)
====================================================================================================================


Net Loss Per Share, Basic and diluted                  $            0.00    $            0.00
=================================================================================================


Weighted Average Number Of Common Shares Outstanding
                                                              15,040,000            15,040,000
=================================================================================================
</TABLE>

<PAGE>

    The accompanying notes are an integral part of these financial statements

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                        INTERIM STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                            (Stated in U.S. Dollars)

<TABLE>
<CAPTION>
--------------------------------------------------------------------------------------------------------------------
                                                                                                     CUMULATIVE
                                                                                 PERIOD FROM         PERIOD FROM
                                                                                  INCEPTION           INCEPTION
                                                              THREE MONTHS       FEBRUARY 20         FEBRUARY 20
                                                                 ENDED             2003 TO             2003 TO
                                                              FEBRUARY 28        FEBRUARY 29         FEBRUARY 28
                                                                  2005               2004               2005
--------------------------------------------------------------------------------------------------------------------
<S>                                                         <C>                 <C>                 <C>
Cash Flows From Operating Activities
     Net loss for the period                                $         (4,079)   $         (6,205)   $        (41,251)

Adjustments To Reconcile Net Loss To Net Cash Used By
  Operating Activities
     Accounts payable                                                   (347)                 --               6,251
                                                            --------------------------------------------------------
                                                                      (4,426)             (6,205)            (35,000)
                                                            --------------------------------------------------------

Cash Flows From Financing Activities
     Loan from shareholder                                                --                  --              10,000
     Issue of common shares for cash                                      --                  --              25,000
                                                            --------------------------------------------------------
                                                                          --                  --              35,000
                                                            --------------------------------------------------------

Decrease In Cash                                                      (4,426)             (6,205)                 --

Cash, Beginning Of Period                                              4,426              14,429                  --
                                                            --------------------------------------------------------

Cash, End Of Period                                         $             --    $          8,224    $             --


Supplemental Disclosure Of Interest And Income Taxes Paid
     Interest paid during the period                        $             --    $             --    $             --
     Income taxes paid during the period                    $             --    $             --    $             --
</TABLE>

<PAGE>

   The accompanying notes are an integral part of these financial statements

                              SALMON EXPRESS INC.
                          (A Development Stage Company)

                    INTERIM STATEMENT OF STOCKHOLDERS' EQUITY

         PERIOD FROM INCEPTION, FEBRUARY 20, 2003, TO FEBRUARY 28, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)

<TABLE>
<CAPTION>
                                                                                         DEFICIT
                                                                                        ACCUMULATED
                                             NUMBER                      ADDITIONAL      DURING THE
                                               OF            PAR          PAID-IN       DEVELOPMENT
                                             SHARES         VALUE         CAPITAL          STAGE           TOTAL
                                          ------------   ------------   ------------    ------------    ------------
<S>                                         <C>          <C>            <C>             <C>             <C>
Shares issued for cash (March 2003)         10,000,000   $     10,000   $     (5,000)   $         --    $      5,000
Shares issued for cash (April 2003)          1,250,000          1,250          1,250              --           2,500
Shares issued for cash (May 2003)            3,750,000          3,750          3,750              --           7,500
Shares issued for cash (July 2003)              40,000             40          9,960              --          10,000
Net loss for the period                             --             --             --         (10,571)        (10,571)
                                          ------------   ------------   ------------    ------------    ------------

Balance, November 30, 2003                  15,040,000         15,040          9,960         (10,571)         14,429

Note payable to a principal stockholder
  contributed as capital (Note 3)                   --             --         10,000              --          10,000
Net loss for the year                               --             --             --         (26,601)        (26,601)
                                          ------------   ------------   ------------    ------------    ------------

Balance, November 30, 2004                  15,040,000         15,040         19,960         (37,172)         (2,172)

Net loss for the three months                       --             --             --          (4,079)         (4,079)
                                          ------------   ------------   ------------    ------------    ------------

Balance, February 28, 2005                  15,040,000   $     15,040   $     19,960    $    (41,251)   $     (6,251)
                                          ============   ============   ============    ============    ============
</TABLE>

<PAGE>

   The accompanying notes are an integral part of these financial statements

                              SALMON EXPRESS INC.
                         (A Development Stage Company)

                     NOTES TO INTERIM FINANCIAL STATEMENTS

                               FEBRUARY 28, 2005
                                  (Unaudited)
                            (Stated in U.S. Dollars)

1.    BASIS OF PRESENTATION

      The unaudited financial statements as of February 28, 2005 included herein
      have been prepared without audit pursuant to the rules and regulations of
      the Securities and Exchange Commission. Certain information and footnote
      disclosures normally included in financial statements prepared in
      accordance with United States generally accepted accounting principles
      have been condensed or omitted pursuant to such rules and regulations. In
      the opinion of management, all adjustments (consisting of normal recurring
      accruals) considered necessary for a fair presentation have been included.
      It is suggested that these financial statements be read in conjunction
      with the November 30, 2004 audited financial statements and notes thereto.

2.    NATURE OF OPERATIONS AND GOING CONCERN

      a)    Nature of Operations

            Salmon Express Inc. (the "Company") was formed and incorporated in
            the State of Nevada on February 20, 2003 and is a development stage
            company. The Company has developed a system of processing (flash
            freezing and cryo-vacuum packaging) and distribution of salmon from
            the North Pacific Ocean.

      b)    Going Concern

            Since its inception, the Company has been dependent upon the
            proceeds of stock sales from its stockholders to fund its continuing
            activities. In addition to the normal risks associated with a new
            business venture, there can be no assurance that the Company's
            product development will be a commercial success. Nor can the
            Company give any assurance that it will generate substantial
            revenues or that its business operations will prove to be
            profitable.

            The accompanying financial statements have been prepared assuming
            that the Company will continue as a going concern. The Company has
            very little revenue and business operations and incurred a net loss
            of $4,079 and negative cash flow from operations of $4,426 for the
            three months ended February 28, 2005 and has an accumulated deficit
            of $41,251. These conditions raise substantial doubt about the
            Company's ability to continue as a going concern.

<PAGE>

            The Company's ability to continue operations is uncertain and is
            dependent upon its ability to achieve profitability, maintain
            current financing and obtain new sources of financing. These
            financial statements do not include any adjustments to the amounts
            and classification of assets and liabilities that might be necessary
            should the Company be unable to continue operations.

<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                FEBRUARY 28, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)


3.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

      a)    Development Stage Enterprise

            The Company is a development stage enterprise as defined by
            Statement of Financial Accounting Standards (SFAS) No. 7,
            "Accounting and Reporting by Development Stage Enterprises." All
            losses accumulated since the inception of the Company have been
            considered as part of the Company's development stage activities.

      b)    Basis of Presentation of Financial Information

            The accompanying financial statements as of February 28, 2005, and
            for the three months then ended, have been prepared in conformity
            with accounting principles generally accepted in the United States
            of America. In the opinion of management, all adjustments
            (consisting only of normal accruals) considered necessary for a fair
            presentation have been included.

      c)    Use of Estimates

            The preparation of the financial statements in conformity with
            accounting principles generally accepted in the United States of
            America requires management to make estimates and assumptions that
            affect the reported amounts of assets and liabilities and of
            contingent assets and liabilities at the date of the financial
            statements and the reported amounts of revenues and expenses during
            the reporting period. Actual results could differ from those
            estimates.

      d)    Loss Per Common Share

            Net loss per common share (basic and diluted) is based on the net
            loss divided by the weighted average number of common shares
            outstanding during each period. Common stock equivalents are not
            included in the calculation of diluted loss per share, because their
            effect would be anti-dilutive. There are no common stock equivalents
            outstanding as of February 28, 2005 and 2004.

      e)    Impairment of Long-Lived Assets

            In August 2001, the Financial Accounting Standards Board ("FASB")
            issued Statement of Financial Accounting Standards ("SFAS") No. 144,
            Accounting for the Impairment of Disposal of Long-Lived Assets
            ("Statement No. 144"). This pronouncement superceded Statement of
            Financial Accounting Standards No. 121, Accounting for the
            Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed
            of ("Statement No. 121") and was required to be adopted on January
            1, 2002.

<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                FEBRUARY 28, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)



3.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Continued)

      e)    Impairment of Long-Lived Assets (Continued)

            Statement No. 144 retained the fundamental provisions of Statement
            No. 121 as it related to assets to be held and used and assets to be
            sold. Statement No. 144 requires impairment losses to be recorded on
            assets to be held and used by the Company when indicators of
            impairment are present and the undiscounted cash flows estimated to
            be generated by those assets are less than the carrying amount of
            the assets. When an impairment loss is required for assets to be
            held and used by the Company, the related assets are adjusted to
            their estimated fair value. Fair value represents the amount at
            which an asset could be bought or sold in a current transaction
            between willing parties, that is, other than a forced or liquidation
            sale.

            The estimation process involved in determining if assets have been
            impaired and in the determination of fair value is inherently
            uncertain because it requires estimates of current market yields as
            well as future events and conditions. Such future events and
            conditions include economic and market conditions, as well as
            availability of suitable financing to fund acquisition and
            development activities. The Company had no revenue producing assets
            as at February 28, 2005 and therefore there is no impairment.

      f)    Recent Accounting Pronouncements

            In April 2003, the FASB issued Statement 149, Amendment of Statement
            133 on Derivative Instruments and Hedging Activities. This statement
            amends and clarifies accounting for derivative instruments,
            including certain embedded derivatives, and for hedging activities
            under Statement 133. Statement 149 is effective for contracts
            entered into or modified after June 30, 2003. Adopting this new
            standard is not expected to have a significant impact on the
            Company's financial statements.

            In May 2003, the FASB issued Statement No. 150, Accounting for
            Certain Financial Instruments with Characteristics of Both
            Liabilities and Equity. The Statement requires that certain
            financial instruments previously classified as equity in statements
            of financial position be classified as liabilities. The provisions
            in Statement 150 are effective for financial instruments ended into
            or modified after May 31, 2003, and otherwise at the beginning of
            the first interim period beginning after June 15, 2003 for public
            companies. Adopting this new standard is not expected to have a
            significant impact on the Company's financial statements.

<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                FEBRUARY 28, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)



3.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Continued)

      f)    Recent Accounting Pronouncements (Continued)

            In November 2004, the FASB issued Statement 151, "Inventory Costs".
            This Statement amends the guidance in ARB No. 43, Chapter 4,
            "Inventory Pricing", to clarify the accounting for abnormal amounts
            of idle facility expense, freight, handling costs, and wasted
            material (spoilage). Statement 151 requires that those items be
            recognized as current period charges regardless of whether they meet
            the criterion of "so abnormal". In addition, this Statement requires
            that allocation of fixed production overheads to the costs of
            conversion be based on the normal capacity of the production
            facilities. Statement 151 is effective for inventory costs incurred
            during fiscal years beginning after June 15, 2005, with earlier
            application permitted in certain circumstances. Adopting this new
            standard is not expected to have a significant impact on the
            Company's financial statements.

            In December 2004, FASB has also issued SFAS No. 152 and 153 but they
            will not have any relationship to the operations of the Company,
            therefore, a description of each and their respective impact on the
            Company's operations have not been disclosed.

      g)    Fair Value of Financial Instruments

            The carrying amounts of the Company's financial instruments, which
            is comprised of accrued liabilities at February 28, 2005,
            approximates their fair values due to the short term nature of these
            instruments.


4.    NOTE PAYABLE

The note payable is interest free and repayable on demand. As the note payable
is due to a principal stockholder, it has been classified into equity as part of
additional paid-in capital.


5.    MERGER AGREEMENT

On January 31, 2005, the Board of Directors approved the following:

      i)    entering into a merger agreement with MicroMed Technology, Inc.
            effective May 1, 2005;
      ii)   reverse stock split of 1 for 3.3528 immediately prior to the merger;
      iii)  reincorporation from the State of Nevada to the State of Delaware;
            and
      iv)   a name change to "Micro Med Cardiovascular Technologies, Inc."

     Majority shareholder approval was also received on January 31, 2005.

<PAGE>

                               SALMON EXPRESS INC.
                          (A Development Stage Company)

                      NOTES TO INTERIM FINANCIAL STATEMENTS

                                FEBRUARY 28, 2005
                                   (Unaudited)
                            (Stated in U.S. Dollars)



5.    MERGER AGREEMENT

      Under the terms of the merger agreement, the Company will incorporate a
      subsidiary which will be merged with MicroMed Technology, Inc.
      ("MicroMed"). Each issued and outstanding share of common stock of the
      subsidiary will be converted into one issued share of the surviving
      corporation. Each fully issued share of MicroMed common stock outstanding
      will be converted into one issued share of the Company's common stock.
      Warrants to purchase shares of MicroMed common stock and options to
      purchase shares of MicroMed common stock outstanding immediately prior to
      the effective date will be assumed by the Company and will become warrants
      to purchase shares of the Company's common stock or options to purchase
      shares of the Company's common stock, as applicable. The shares of the
      Company owned by the current majority shareholder will be cancelled and
      all the pre-merger assets and liabilities will be transferred to that
      shareholder.


Item 2. Management's Discussion and Analysis or Plan of Operations

Plan of Operation

We are presently attempting to implement our three streams for generating
revenue: the sale and delivery of salmon products through our website
salmonx.com; the sale and delivery of salmon products through our 1-800 phone
line; and the sale and delivery of other seafood products when in season through
both the web site and the 1-800 phone line. We have established distribution
channels to meet any orders we receive. In the future, we may obtain cold
storage space (suitable for holding flash frozen seafood products) and establish
an inventory of Salmon Express products. Ultimately, once we can predict demand,
establishing an inventory will improve our ability to obtain whole-sale prices
for seafood products and make quality control and delivery more efficient. We
intend to maintain good relationships with a number of salmon suppliers in our
target geographic region so that our inventory can be maintained, diminished or
increased depending on initial consumer response.

We have been sending brochures to our niche customers. These brochures highlight
the superior quality of our product, the products available, ordering
information and prices. We also market Salmon Express products through our
internet web-site, which uses pictures, slogans and various search engine hit
maximization strategies to market our product platform.

Funds received from our private offerings have provided us with enough funds to
execute the initial stages of our business plan which includes the initial

<PAGE>

development of our internet web site and 1-800 ordering service, our product and
logo development, development of key products, and the ongoing establishment of
distribution agreements with key high-end salmon distributors. Under currently
anticipated budgetary constraints, and assuming we fail to generate any revenues
in our first year of operation, we anticipate that we can maintain an
operational Internet web site, being Salmonx.com, an operational 1-800 number
service, distribution channels with high quality salmon products distributors,
and keep several Salmon Express products available, in various packaging
schemes, for order and fast delivery.

Our marketing efforts to date have yielded little if any results. Unless our
marketing becomes more effective than it has been to date, we will be forced to
close the business or find more effective ways of conducting our business.

In light of the lack of results to our marketing efforts to date, our President
has initiated discussions with MicroMed Technology, Inc. ("MicroMed"), a
privately held Delaware corporation based in Houston, Texas, to merge a
subsidiary of Salmon Express with and into MicroMed, with MicroMed as the
surviving entity at the subsidiary level. On February 3, 2005 and March 30,
2005, respectively, the Company filed a form PREM14C and form PRER14C with the
Securities Exchange Commission of the United States pursuant to a proposed
Agreement and Plan of Merger with MicroMed. MicroMed is a medical device company
focused on the development of ventricular assist device ("VAD") products.
MicroMed has developed a miniaturized heart pump, or VAD, known as the DeBakey
VAD (the "DeBakey VAD") to address congestive heart failure, a condition where
the diseased heart cannot pump adequate blood to meet the oxygen and nutritional
needs of the body. The DeBakey VAD is a small (1 inch x 3 inches) National
Aeronautics and Space Administration designed axial flow pump that can provide
increased blood flow from the left ventricle of the heart throughout the body
for patients whose hearts are diseased and unable to maintain adequate blood
flow to sustain their lives.

Liquidity

To jump start our business plan and to operate our business for the next 12
months, we believe we will need approximately $50,000. We plan on obtaining this
operating capital from our own available funds, and we expect to raise capital
through the sale of equity capital if business revenues are not available to pay
necessary expenses. However, if funds are not available from these sources, our
director and President, Mr. Pete Smith has agreed to loan Salmon Express up to
$50,000 in furtherance of our plan of operations for the next twelve months. The
cash on hand we have at the present time will sustain the operations of Salmon
Express for approximately two months. We do not anticipate the need for any
additional employees during the next twelve months other than the services of
the individuals discussed above, unless initial response to our products is
extremely positive and orders are more numerous than expected.

Going Concern

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. The Company has very little revenue
and business operations and incurred a net loss of $4,079 and negative cash flow

<PAGE>

from operations of $4,426 for the three month period ended February 28, 2005,
and net loss of $26,601 for the year ended November 30, 2004. These conditions
raise substantial doubt about the Company's ability to continue as a going
concern.

Funds received from the Company's private offerings have provided the Company
with enough funds to execute the initial stages of the Company's business plan
which includes the initial development of the Company's internet web site and
1-800 ordering service, the Company's product and logo development, development
of key products, and the ongoing establishment of distribution agreements with
key high-end salmon distributors in the region the Company intends to market.
Under currently anticipated budgetary constraints, and assuming the Company
fails to generate any revenues in its first year of operation commencing in the
fourth quarter of 2004, the Company anticipates that it will have an operational
Internet web site, being Salmonx.com, an operational 1-800 number service,
distribution channels established with high quality salmon products
distributors, and several Salmon Express products available, in various
packaging schemes, for order and fast delivery. For further information relevant
to the Company's ability to continue as a going concern, see section "Liquidity
and Capital Resources" above.

                           Forward-Looking Statements:
Many statements made in this report are forward-looking statements that are not
based on historical facts. Because these forward-looking statements involve
risks and uncertainties, there are important factors that could cause actual
results to differ materially from those expressed or implied by these
forward-looking statements. The forward-looking statements made in this report
relate only to events as of the date on which the statements are made.



Recent Accounting Pronouncements

In January 2003, (as revised in December 2003) The Financial Accounting
Standards Board ("FASB") issued Interpretation No. 46, "Consolidation of
Variable Interest Entities", an interpretation of Accounting Research Bulletin
("ARB") No. 51, "Consolidated Financial Statements". Interpretation No. 46
addresses consolidation by business enterprises of variable interest entities,
which have one or both of the following characteristics: (i) the equity
investment at risk is not sufficient to permit the entity to finance its
activities without additional subordinated support from other parties, which is
provided though other interest that will absorb some or all of the expected
losses of the entity: (ii) the equity investors lack one or more of the
following essential characteristics of a controlling financial interest: the
direct or indirect ability to make decisions about the entities activities
through voting rights or similar rights; or the obligation to absorb the
expected losses of the entity if they occur, which makes it possible for the
entity to finance its activities; the right to receive the expected residual
returns of the entity if they occur, which is the compensation for the risk of
absorbing the expected losses.

Interpretation No. 46, as revised, also requires expanded disclosures by the
primary beneficiary (as defined) of a variable interest entity and by an
enterprise that holds a significant variable interest entity and by an
enterprise that holds a significant variable interest in a variable interest
entity but is not the primary beneficiary.

<PAGE>

Interpretation No. 46, as revised, applies to small business issuers no later
than the end of the first reporting period that ends after December 15, 2004.
This effective date included those entities to which Interpretation No. 46 has
previously been applied. However, prior to the required application of
Interpretation No. 46, a public entity that is a small business issuer shall
apply purpose entities no later than as of the end of the first reporting period
that ends after December 15, 2003.

Interpretation No. 46 may be applied prospectively with a cumulative-effect
adjustment as of the date on which it is first applied or by restating
previously issued financial statements for one or more years with a
cumulative-effect adjustment as of the beginning of the first year restated.

In June 2003, the FASB issued an Exposure Draft for a proposed SFAS entitled
"Qualifying Special Purpose Entities ("QSPE") and Isolation of Transferred
Assets", an amendment of SFAS No. 140 ("The Exposure Draft"). The Exposure Draft
is a proposal that is subject to change and as such is not yet authoritative. If
the proposal is enacted in its current form, it will amend and clarify SFAS 140.
The Exposure Draft would prohibit an entity from being a QSPE if it enters into
an agreement that obligated a transferor of financial assets, its affiliates or
its agents to deliver additional cash or other assets to fulfill the
special-purposes entity's obligation to beneficial interest holders.

In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement 133 on
Derivative Instruments and Hedging Activities". SFAS No. 149 amends and
clarifies financial accounting reporting for derivative instruments, including
certain derivative instruments embedded in other contracts (collectively
referred to as derivatives) and for hedging activities under SFAS No. 133,
"Accounting for Derivative Instruments and Hedging Activities". The changes in
SFAS No. 149 improve financial reporting by requiring that contracts with
comparable characteristics be accounted for similarly. This statement is
effective for contracts entered into or modified after June 30, 2003 and all of
its provisions should be applied prospectively.

In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial
Instruments with Characteristics of both Liabilities and Equity". SFAS No. 150
changes the accounting for certain financial instruments with characteristics of
both liabilities and equity that, under previous pronouncements, issuers could
account for as equity. The new accounting guidance contained in SFAS No. 150
requires that those instruments be classified as liabilities in the balance
sheet.

SFAS No. 150 affects the issuer's accounting for three types of freestanding
financial instruments. One type is mandatory redeemable shares, which the
issuing company is obligated to buy back in exchange for cash and other assets.
A second type includes put options and forward purchase contracts, which
involves instruments that do or may require the issuer to buy back some of its
shares in exchange for cash or other assets. The third type of instruments that
are liabilities under this Statement is obligations that can be settled with
shares, the monetary value of which is fixed, tied solely or predominantly to a
variable such as a market index, or varies inversely with the value of the
issuer's shares.

<PAGE>

SFAS No. 150 does not apply to features embedded in a financial instrument that
is not a derivative in its entirety. Most of the provisions of Statement 150 are
consistent with the existing definition of liabilities in FASB Concepts
Statements No. 6, "Elements of Financial Statements". The remaining provisions
of this Statement are consistent with the FASB's proposal to revise that
definition to encompass certain obligations that a reporting entity can or must
settle by issuing its own shares. This Statement shall be effective for
financial instruments entered into or modified after May 31, 2003 and otherwise
shall be effective at the beginning of the first interim period beginning after
June 15, 2003, except for mandatory redeemable financial instruments of a
non-public entity, as to which the effective date is for fiscal periods
beginning after December 15, 2003.

Management does not expect the implementation of these recent pronouncements to
have a material effect on the Company's financial position of results of
operations.

Item 3.  Controls and Procedures.

As of the end of the period covered by this report, Management carried out an
evaluation of the effectiveness of the design and operation of the Company's
disclosure controls and procedures, pursuant to Exchange Act Rule 13a-15(c) and
15d-15(c) which includes inquiries made to certain other of our employees. Based
on the foregoing, the Principal Executive Officer and Principal Financial
Officer concluded that the Company's disclosure controls and procedures are
effective to timely alert them to any material information relating to the
Company that must be included in the Company's' periodic SEC filings. In
addition, there have been no significant changes in the Company" internal
controls over financial reporting that occurred during the fiscal quarter
covered by this quarterly report that has materially affected, or is reasonably
likely to materially affect, the Company's internal control over financial
reporting.

PART II - OTHER INFORMATION

Item 4.  Submission of Matters to a Vote of Securities Holders

On February 3, 2005 and March 30, 2005, respectively, the Company filed a form
PREM14C and form PRER14C with the Securities Exchange Commission of the United
States pursuant to a proposed Agreement and Plan of Merger (the "Merger
Agreement") with MicroMed Technology, Inc. ("MicroMed"), a privately held
Delaware corporation based in Houston, Texas. The Merger is to be accomplished
through our wholly-owned merger subsidiary in Nevada ("Merger Sub"), which will
merge with and into MicroMed, with MicroMed being the survivor. We will issue
shares of our common stock on a one-for-one basis to the stockholders of
MicroMed in exchange for 100% of the issued and outstanding shares of common
stock of MicroMed. Additionally, we will assume options to purchase shares of
common stock and warrants to purchase shares of common stock on the same terms
and conditions as previously issued by MicroMed. All outstanding options that
will be assumed by us have been issued under the MicroMed 1997 Stock Option Plan
or the MicroMed 2005 Stock Incentive Plan. Further to the Merger, we will assume

<PAGE>

the MicroMed 1997 Stock Option Plan and the MicroMed 2005 Stock Incentive Plan
as stock option plans of Salmon. We will also issue 1,500,000 post-split shares
into escrow to cover indemnification obligations, if any, to MicroMed and its
stockholders. Immediately prior to the Merger, we will effectuate a 1-for-3.3528
reverse stock split of our common stock (the "Stock Split"). After the Merger is
concluded, we will reincorporate from the State of Nevada to the State of
Delaware (the "Reincorporation") and change our corporate name to MicroMed
Cardiovascular, Inc., or such other name as MicroMed may select prior to closing
(the "Name Change"). Further to the Merger, we will also cancel 10,010,800
shares of our pre-split common stock held by Pete Smith and distribute assets,
and related liabilities, to him that we held prior to the Merger.

The Merger will result in a change-in-control of Salmon by MicroMed's management
and its stockholders and the assumption of MicroMed's operations and
liabilities.

Because the contemplated Merger is to be accomplished by the Merger Sub, a vote
by our stockholders was not required by the Nevada Revised Statutes. However,
because members of our Board of Directors are interested parties to the Merger,
we obtained the written consent of the holders of a majority of our common
stock.

The affirmative vote of the holders of a majority of our outstanding voting
stock is sufficient to effectuate the Stock Split. The Nevada Revised Statute
provides that any action which may be taken at a meeting of the stockholders may
be taken without a meeting and without prior notice, if a consent in writing,
setting forth the action so taken, shall be signed by the holders of a majority
of the outstanding shares entitled to vote.

On January 31, 2005, there were 15,040,000 shares of common stock outstanding.
The holders of our common stock are entitled to one vote for each share held of
record on all matters submitted to a vote of our stockholders. Thus, we needed
the affirmative vote of 7,520,001 shares to approve the Stock Split. By action
of written consent, dated January 31, 2005, holders of a majority of our
outstanding shares of common stock approved the Stock Split. As a result,
adoption of the Stock Split was approved and no further votes will be needed.

The affirmative vote of the holders of a majority of our outstanding voting
stock is sufficient to effectuate the Name Change and the Reincorporation. The
Nevada Revised Statute provides that any action which may be taken at a meeting
of the stockholders may be taken without a meeting and without prior notice, if
a consent in writing, setting forth the action so taken, shall be signed by the
holders of a majority of the outstanding shares entitled to vote.

On January 31, 2005, there were 15,040,000 shares of common stock outstanding.
The holders of our common stock are entitled to one vote for each share held of
record on all matters submitted to a vote of our stockholders.

Thus, we needed the affirmative vote of 7,520,001 shares to approve the Name
Change and the Reincorporation. By action of written consent, dated January 31,
2005, holders of a majority of our outstanding shares of common stock approved
the Name Change and the Reincorporation. As a result, adoption of the Name
Change and the Reincorporation was approved and no further votes will be needed.

The Merger will not be effective until the Articles of Merger and Certificate of
Merger are filed with the Nevada Secretary of State and the Delaware Secretary
of State, as applicable. The Stock Split will not be effective until we file a

<PAGE>

Certificate of Amendment to Articles of Incorporation with the Nevada Secretary
of State. The Reincorporation and the Name Change will not be effective until we
file a Certificate of Incorporation with the Delaware Secretary of State and an
Agreement and Plan of Merger with the Nevada Secretary of State and the Delaware
Secretary of State. We intend to file these documents approximately 20 calendar
days after our form PRER14C information statement, filed March 30, 2005, is
first mailed to our stockholders.


Item 6. Exhibits and Reports on Form 8-K.

(a)   Exhibits

      31.1  Certification of CEO and CFO pursuant to Securities Exchange Act
            rules 13a-15 and 15d-15(c) as adopted pursuant to section 302 of the
            Sarbanes-Oxley act of 2002.
      32.1  Certification of CEO and CFO pursuant to 18 U.S.C. section 1350, as
            adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

(b)   Reports on Form 8-K

      i)    On March 21, 2005, the Registrant filed its amended report on Form
            8-K/A disclosing its change in certifying accountant under item
            4.01; and
      ii)   On February 2, 2005, the Registrant filed its current report on Form
            8-K disclosing Entry into a Material Definitive Agreement.

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

SALMON EXPRESS INC.


By: /s/ Pete Smith
    ---------------------------------
    Pete Smith
    CEO and CFO
    (Principal Executive Officer)
    (Principal Financial Officer)
    (Principal Accounting Officer)

    Date: April 14, 2005